Sino Biopharmaceutical: Share registrar change, board meeting set

Sino Biopharmaceutical (HKEX: 1177) is set to change its Hong Kong branch share registrar and transfer office to Tricor Investor Services Limited, effective March 31, 2025. Consequently, share certificates not collected by close of business March 28, 2025, will be available at the new registrar from March 31. In addition, the company will hold a board meeting on Thursday, 20 March 2025. At this meeting, the board will review and approve the publication of its annual results for the fiscal year ended December 31, 2024, and consider the recommendation of a final dividend. In related news, the company's monthly return on movements in securities ending February 28, 2025 reported a decrease of 21.5 million in issued ordinary shares, and the maturing of EUR2.15million in bonds. Shares had been repurchased but cancelled. The new announcements were authorised by the board, which comprises six executive and five independent non-executive directors.